MARKET

UTHR

UTHR

United Therapeutics Corp.
NASDAQ
486.88
+2.78
+0.57%
Opening 14:39 12/05 EST
OPEN
484.65
PREV CLOSE
484.10
HIGH
487.40
LOW
481.61
VOLUME
127.75K
TURNOVER
--
52 WEEK HIGH
492.62
52 WEEK LOW
266.98
MARKET CAP
20.96B
P/E (TTM)
18.43
1D
5D
1M
3M
1Y
5Y
1D
SPMD, COHR, LITE, UTHR: Large Outflows Detected at ETF
NASDAQ · 4h ago
Can Merck's New Products Aid Growth as Keytruda LOE Test Looms?
NASDAQ · 1d ago
United Therapeutics (UTHR): Revisiting Valuation After Q3 2025 Growth, Strong 2027 Guidance and Rising Institutional Interest
Simply Wall St · 1d ago
United Therapeutics CFO and Treasurer James Edgemond Reports Disposal of Common Shares
Reuters · 2d ago
United Therapeutics CEO Martine Rothblatt Reports Disposal of Common Shares
Reuters · 2d ago
United Therapeutics President and COO Michael Benkowitz Reports Disposal of Common Shares
Reuters · 2d ago
United Therapeutics management to meet with Oppenheimer
TipRanks · 2d ago
$100 Invested In United Therapeutics 20 Years Ago Would Be Worth This Much Today
Benzinga · 3d ago
More
About UTHR
United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder product.

Webull offers United Therapeutics Corp stock information, including NASDAQ: UTHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UTHR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UTHR stock methods without spending real money on the virtual paper trading platform.